Determine your risk of passing on over 300 genetic diseases to your future child.
80% of children born with a genetic condition have no family history of that disease. CarrierMap is an expanded carrier screen that can help you plan for a healthy family.
CarrierMap is recommended for people who are planning a family or early in pregnancy.
Gain insight into the health of your pregnancy with one simple blood test.
Chromosome abnormalities such as Down syndrome impact over 1 in 107 pregnancies. ChromoMap is a non-invasive prenatal screen to assess risk for these conditions.
ChromoMap is available for women who are at least 10 weeks pregnant.
Contribute to a first-of-its-kind study on the links between genomics and infertility.
1 in 6 couples are impacted by infertility. Through large-scale research, FertilityMap seeks to optimize fertility treatment, helping more families achieve successful pregnancies.
Participation in FertilityMap is currently only open to patients of partner clinics.
Navigate the complicated world of genomics with help from Recombine’s expert genetic counselors.
Recombine is focused on comprehensive patient care and offers detailed genetic counseling pre- and post-test to help give the most complete picture of your family’s risk.
Recombine genetic counseling is available alongside CarrierMap and ChromoMap at no additional charge.
Phone: 855-OUR-GENES (855-687-4363)
Location: 1140 Broadway, Suite 1100, New York 10001
Complete genetic counseling support ›
High quality, low failure rate ›
Rigorously-validated sequencing technology ›
Seamless integration into your practice ›
As a part of our commitment to responsible medicine, Recombine is proud to offer pre- and post-test genetic counseling to all patients, as well as clinician support throughout every step of the testing process.
Our board-certified expert genetic counselors will guide your patients through their results in the context of their personal, pregnancy, and family medical history, as well as write up a detailed summary letter of every consult, keeping you involved and informed. Follow-up is carefully and expeditiously coordinated with your practice to develop a customized care plan for all patients with ‘Suspected’ or ‘Detected’ ChromoMap results.
ACOG, ACMG, and NSGC recommend that all pregnant women regardless of age, ethnicity, and prior risk be offered the option of prenatal screening. ChromoMap is designed to give you and your patient vital information about fetal chromosome health as early as 10 weeks of pregnancy and requires only a single tube of maternal blood.
Powered by Illumina, Recombine’s ChromoMap has the lowest failure rate in the NIPS industry, meaning fewer sample redraws and overall faster results to you and your patients.
Grounded in scientific and clinical research, ChromoMap uses a deep sequencing approach and custom algorithm to screen for the most clinically relevant panel of chromosome abnormalities. The core ChromoMap panel includes Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). Optional add-on panels are also available at no additional charge.
At Recombine, we are dedicated to providing superior testing and an overall seamless experience. ChromoMap requires only one tube of maternal blood, requires no paternal sample, and is also available to patients using egg donors. Reports are available within 3-5 days following the sample’s arrival at the Recombine laboratory and provide a clear picture of fetal risk.
CarrierMap is offered alongside ChromoMap to provide the most complete look into the health of your patient’s growing family.